Ju Fu Tang Biotech Holdings Co., Ltd (HKG:8217)

HKG:8217 Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 19, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	110	63	27	36	50	43
Market Cap Growth	80.69%	137.50%	-26.67%	-28.14%	17.08%	72.50%
Enterprise Value	70	56	22	14	111	155
Last Close Price	0.36	0.21	0.09	0.12	0.17	0.40
PE Ratio	5.52	-	-	-	-	-
PS Ratio	4.00	1.74	0.76	0.35	0.54	0.26
PB Ratio	2.26	2.32	0.80	0.72	0.83	1.74
P/TBV Ratio	2.26	2.32	0.80	0.72	0.83	1.74
P/FCF Ratio	-	-	7.14	1.12	-	1.51
P/OCF Ratio	-	-	7.14	1.12	-	1.51
EV/Sales Ratio	2.55	1.55	0.62	0.13	1.20	0.92
EV/FCF Ratio	-	-	5.88	0.44	-	5.43
Debt / Equity Ratio	0.29	0.72	0.43	0.44	0.91	4.34
Debt / FCF Ratio	-	-	3.83	0.68	-	3.76
Net Debt / Equity Ratio	-0.82	-0.39	-0.38	-0.44	0.17	2.41
Net Debt / EBITDA Ratio	3.32	0.94	3.00	1.76	-0.49	-4.28
Net Debt / FCF Ratio	8.10	1.45	-3.34	-0.69	-0.53	2.09
Asset Turnover	0.31	0.45	0.38	0.84	0.60	0.89
Quick Ratio	1.78	1.33	1.58	1.83	1.63	1.26
Current Ratio	1.97	1.51	1.68	1.91	1.71	1.28
Return on Equity (ROE)	52.51%	-19.55%	-41.67%	-17.94%	-47.25%	-46.91%
Return on Assets (ROA)	-8.38%	-8.69%	-2.83%	-6.34%	-8.74%	-5.28%
Return on Invested Capital (ROIC)	-138.19%	-60.24%	-17.28%	-25.52%	-27.68%	-14.00%
Return on Capital Employed (ROCE)	-24.90%	-41.30%	-12.80%	-25.10%	-35.50%	-43.20%
Earnings Yield	18.37%	-9.35%	-65.63%	-27.50%	-39.97%	-30.50%
FCF Yield	-	-11.52%	14.01%	88.98%	-38.71%	66.30%
Buyback Yield / Dilution	-1.51%	-	-	-50.37%	-131.26%	-11.29%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.